USA - NASDAQ:NERV - US6033802058 - Common Stock
ChartMill assigns a Buy % Consensus number of 43% to NERV. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-06 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2025-02-26 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-11-06 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-08-07 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2024-05-02 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2024-02-27 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2023-08-02 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2023-05-16 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2023-05-02 | HC Wainwright & Co. | Reiterate | Neutral |
| 2023-03-09 | HC Wainwright & Co. | Reiterate | Neutral |
| 2022-11-10 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2022-10-17 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2022-03-04 | HC Wainwright & Co. | Maintains | Buy |
6 analysts have analysed NERV and the average price target is 5.1 USD. This implies a price increase of 28.46% is expected in the next year compared to the current price of 3.97.
The consensus rating for MINERVA NEUROSCIENCES INC (NERV) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
The number of analysts covering MINERVA NEUROSCIENCES INC (NERV) is 6.